Abstract
Objective: Animal studies have demonstrated that monoclonal antibodies like guselkumab (GUS) cross the placenta. Although pregnant women and women who intend to become pregnant were excluded from participation in GUS clinical trials, some female patients still became pregnant during the study period and discontinued GUS. Here, we report these pregnancy experiences.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
